Vildagliptin

CAS: 274901-16-5

Ref. TM-T1502

Informação sobre produto

• Nome: Vildagliptin
• Sinónimos: NVP-LAF 237, LAF237, (-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1[3,7]]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile, (2S)-1-[2-[(3-Hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile, (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.1^3,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile, (2S)-1-[N-(3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl)glycyl]pyrrolidine-2-carbonitrile, (3R)-3-amino-1-[6-(trifluoromethyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphate (1:1), (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile, 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.1^3,7]dec-1-yl)amino]acetyl]-, (2S)-, 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.1^3,7]dec-1-yl)amino]acetyl]-, (2S)-, Dsp 7238, Galvus, Jalra, Laf 237, Nvp-Laf 237, Vidagliptin, Xiliarx, 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-, 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-, (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile

Descrição

Vildagliptin (LAF237), an oral DPP-4 inhibitor with hypoglycemic effects, is metabolized and excreted in urine.

• Marca: Targetmol

Propriedades químicas

• Peso molecular: 303.4
• Fórmula: C₁₇H₂₅N₃O₂
• Pureza: 100% - 99.03%
• Cor/forma: White Crystalline Powder